Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J2785
    Short Description Regadenoson injection
    Long Description Injection, regadenoson, 0.1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2014-01-01
    Date Added 2009-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00409140101 J2785 Regadenoson injection REGADENOSON HOSPIRA, INC. 0.1 MG 5 10 4 40
    00469650189 J2785 Regadenoson injection Regadenoson ASTELLAS PHARMA US INC. 0.1 MG 5 1 4 4
    00641625301 J2785 Regadenoson injection REGADENOSON HIKMA PHARMACEUTICALS USA 0.1 MG 5 1 4 4
    16729047731 J2785 Regadenoson injection Lexican ACCORD HEALTHCARE INC. 0.1 MG 5 1 4 4
    43598061611 J2785 Regadenoson injection Regadenoson DR.REDDY'S LABORATORIES, INC. 0.1 MG 5 1 4 4
    55150044301 J2785 Regadenoson injection REGADENOSON EUGIA US LLC 0.1 MG 5 1 4 4
    67457099405 J2785 Regadenoson injection REGADENOSON MYLAN INSTITUTIONAL 0.1 MG 5 1 4 4
    71288020185 J2785 Regadenoson injection REGADENOSON MEITHEAL PHARMACEUTICALS, INC. 0.1 MG 5 1 4 4
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].